slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,557
Current window 38,341-38,370
Pages 2,019
Rows per page 30
Component
38,341-38,370 of 60,557
09
The slide uses a dual-table layout to segment clients into 'Brands' and 'Retailers', emphasizing the longevity of these partnerships.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
17
Includes detailed footnotes regarding debt terms and equity instruments.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
20
Includes footnotes (1) through (9) referenced in the table rows.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
22
This is a standard financial disclosure table showing historical adjustments to GAAP net income.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
24
This is a standard financial disclosure slide for non-GAAP metrics.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
06
Red boxes highlight key clinical history metrics: time since diagnosis, splenectomy history, prior therapies, and concurrent therapy usage.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Agitation1 hit
07
The slide uses a hierarchical testing procedure for statistical significance.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Solution1 hit
09
The slide uses a stacked bar chart to visualize the response rates and a table to detail specific IWG criteria outcomes.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Comparative Analysis1 hit
13
The table compares adverse events (TEAEs) and specific common events between treatment and placebo groups.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
16
Includes a forest plot for subgroup analysis and a summary table for prior treatments.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
09
The table provides a reconciliation of GAAP to Non-GAAP operating expenses, highlighting the impact of stock-based compensation, restructuring, and legal/transaction costs.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Need1 hit
10
Includes a disclaimer regarding non-GAAP measures and rounding.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Need1 hit
11
The table provides year-over-year and quarter-over-quarter percentage changes for inventory categories.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations 1 hit
16
The table provides a detailed breakdown of R&D, S&M, and G&A expenses, adjusting for stock-based compensation, restructuring, and legal/transaction costs.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Satisfaction1 hit
18
Sonos | Results Presentation Deck | 41 slidesSonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
31
Includes a table of historical household data (2018-2022) and a revenue bridge calculation.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
32
Sonos | Results Presentation Deck | 41 slidesSonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
35
The slide highlights a strategic shift toward higher-margin channels (DTC and IS) which now account for 44% of total revenue.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
36
Includes non-GAAP metrics and constant currency growth rates.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
39
Includes footnotes explaining restructuring expenses and legal/transaction costs.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
40
Note: $ in thousands, unaudited.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
08
The table highlights accretion in both Revenue/Share and Adjusted EBITDA/Share.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Problem (Identify pain)Loop · Before After1 hit
11
Includes footnotes explaining financial income and non-recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
22
The slide provides a standard 'Table 1' style clinical trial baseline characteristic summary.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
23
The slide shows patient counts and percentages for study completion and various reasons for discontinuation.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
28
The slide includes a table of adverse events and bulleted takeaways regarding clinical safety parameters.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
37
The slide provides a summary of patient characteristics to demonstrate baseline comparability.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
42
The slide includes a footnote defining abbreviations and study parameters.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
12
The table uses arrows to indicate the direction of guidance revisions (upward or flat).Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
19
The table includes both absolute dollar values and percentage margins for each quarter.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit